Immuneering (IMRX) Assets (2020 - 2024)
Historic Assets for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $68.6 million.
- Immuneering's Assets fell 3979.93% to $68.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $68.6 million, marking a year-over-year decrease of 3979.93%. This contributed to the annual value of $102.6 million for FY2023, which is 1616.67% down from last year.
- Per Immuneering's latest filing, its Assets stood at $68.6 million for Q3 2024, which was down 3979.93% from $77.1 million recorded in Q2 2024.
- Immuneering's 5-year Assets high stood at $166.7 million for Q4 2021, and its period low was $38.4 million during Q4 2020.
- In the last 5 years, Immuneering's Assets had a median value of $113.9 million in 2023 and averaged $110.4 million.
- As far as peak fluctuations go, Immuneering's Assets skyrocketed by 33386.71% in 2021, and later tumbled by 3979.93% in 2024.
- Quarter analysis of 5 years shows Immuneering's Assets stood at $38.4 million in 2020, then skyrocketed by 333.87% to $166.7 million in 2021, then decreased by 26.6% to $122.4 million in 2022, then fell by 16.17% to $102.6 million in 2023, then plummeted by 33.17% to $68.6 million in 2024.
- Its Assets was $68.6 million in Q3 2024, compared to $77.1 million in Q2 2024 and $88.0 million in Q1 2024.